Tag Archives: Payers

Digital therapeutics in demand, but support needed from payers

Digital therapeutics can be used to prevent, manage or treat diseases—particularly chronic conditions—but their widespread use is stalled for lack of reimbursement from private and public payers. According to a new study by data and analytics company GlobalData, entitled, “Digital Therapeutics and Their Impact on Healthcare,” there is a growing number of digital therapeutics (DTx)… Read More »